https://www.selleckchem.com/products/sb225002.html
Additionally, vascular function was improved in diabetic vessels of mice treated with MCC950 (P less then 0.05). In a range of cell lines (murine bone marrow-derived macrophages, human monocytic THP-1 cells, phorbol 12-myristate 13-acetate-differentiated human macrophages, and aortic smooth muscle cells from humans with diabetes), MCC950 significantly reduced IL-1β and/or caspase-1 secretion and attenuated leukocyte-smooth muscle cell interactions under high glucose or lipopolysaccharide conditions. In summary, MCC950 reduces plaque de
Aimer
Commentaire
Partagez
